The Law Firm of Spiegel Brown Fichera & Coté, LLP is accepting cases on behalf individuals who have experienced Ulcerative Colitis, Chron’s Diesease, or other Inflammatory Bowel Disease (IBD) as a result of Accutane® use
If you or a loved one suffers from Ulcerative Colitis or other Inflammatory Bowel Disease (IBD) as a result of Accutane use please click this link for a free consultation or call us at (845) 452-7400 or (845) 831-8840. You may be entitled to money damages.
We are accepting cases brought by individuals who have taken either Accutane® or any of its generic forms, marketed as Amnesteen, Racutane, Claravis and Sotret
Accutane® is the brand name for the drug known as isotretinoin. Isotretinoin is part of a class of drugs known as retinoids and its active ingredient is derived from Vitamin A. Accutane and its generic forms are prescribed for the treatment of severe recalcitrant acne. The drug works by decreasing facial oil production.
Accutane® Inflammatory Bowel Disease, Ulcerative Colitis and Crohn’s Disease
Inflammatory Bowel Disease, or “IBD” is a sort of “catch all” term medical disorders that are marked by inflammation of the intestines. Intestinal or bowel inflammation is long-lasting and is known to “wax and wane”. In other words it is chronic, and even when it appears to have disappeared — it is likely to return.
Symptoms often initially mimic the common stomach flu and include:
* Severe abdominal pain
* Pain in the joints
* Sudden weight loss
* Loss of appetite
* Skin conditions
* Rectal bleeding
There is no known cure for any form of IBD.
Irritable Bowel Disease is generally broken into two types of disease; Ulcerative Colitis and Crohn’s disease.
Ulcerative colitis often causes ulcers and inflammation in the large intestine.
Crohn’s disease usually affects the small intestine, but can occur in all portions of the digestive tract, including the mouth, stomach, and colon.
In 2006 the American Journal of Gastroenterology published a study that identified a link between the use of isotretinoin and the development of IBD.
In March 30, 2010, an article published in the same journal linked Accutane (and generic isotretinoin) to bowel problems.
The study determined Accutane (isotretinoin) use increased the risk of IBD as much as a factor of four depending on the daily dosage.
As of February 2010, all six plaintiffs bringing Accutane® IBD lawsuits against drug maker Roche Laboratories, Inc., have won (one judgment has been overturned by a Florida appeals court.) Juries finding for the Accutane® plaintiffs believed that Roche Laboratories failed to adequately warn physicians and patients of the IBD risk associated with Accutane® use.
In November 2008, for example, a New Jersey jury ordered the company to pay $13 million to three such plaintiffs. The previous April, another New Jersey jury awarded $10.5 million to a woman who blamed the drug for her ulcerative colitis.
In May 2007, another New Jersey trial resulted in an award of $2.62 million to a patient who needed to have his colon and most of his rectum removed after taking the drug. In October that same year, a Florida jury awarded $7 million in damages to another Accutane user who developed IBD.
In June of 2009, Roche halted Accutane® sales, citing the availability of generic isotretinoin and the cost of defending Accutane® lawsuits as its reason for no longer marketing the drug. The pharmaceutical giant’s legal troubles with Accutane® continue to grow as more than 800 Accutane® lawsuits have been assigned to mass tort court before Superior Court Judge Carol Higbee in Atlantic City, NJ.
If you have taken accutane or its generic forms, contact us immediately for a free case evaluation. Do not delay as your claim can become time barred by the applicable statute of limitations.